Correlation Between Symtek Automation and Handa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Symtek Automation and Handa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Symtek Automation and Handa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Symtek Automation Asia and Handa Pharmaceuticals, you can compare the effects of market volatilities on Symtek Automation and Handa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Symtek Automation with a short position of Handa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Symtek Automation and Handa Pharmaceuticals.

Diversification Opportunities for Symtek Automation and Handa Pharmaceuticals

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Symtek and Handa is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Symtek Automation Asia and Handa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Handa Pharmaceuticals and Symtek Automation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Symtek Automation Asia are associated (or correlated) with Handa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Handa Pharmaceuticals has no effect on the direction of Symtek Automation i.e., Symtek Automation and Handa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Symtek Automation and Handa Pharmaceuticals

Assuming the 90 days trading horizon Symtek Automation is expected to generate 11.93 times less return on investment than Handa Pharmaceuticals. But when comparing it to its historical volatility, Symtek Automation Asia is 2.02 times less risky than Handa Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Handa Pharmaceuticals is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  5,220  in Handa Pharmaceuticals on October 7, 2024 and sell it today you would earn a total of  2,550  from holding Handa Pharmaceuticals or generate 48.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Symtek Automation Asia  vs.  Handa Pharmaceuticals

 Performance 
       Timeline  
Symtek Automation Asia 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Symtek Automation Asia are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Symtek Automation showed solid returns over the last few months and may actually be approaching a breakup point.
Handa Pharmaceuticals 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Symtek Automation and Handa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Symtek Automation and Handa Pharmaceuticals

The main advantage of trading using opposite Symtek Automation and Handa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Symtek Automation position performs unexpectedly, Handa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Handa Pharmaceuticals will offset losses from the drop in Handa Pharmaceuticals' long position.
The idea behind Symtek Automation Asia and Handa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance